@article{3104449,
    title = "Use of triiodothyronine to treat critically ill COVID-19 patients: A new clinical trial",
    author = "Pantos, C. and Tseti, I. and Mourouzis, I.",
    journal = "Critical Care and Resuscitation",
    year = "2020",
    volume = "24",
    number = "1",
    publisher = "BioMed Central Ltd.",
    doi = "10.1186/s13054-020-02934-2",
    keywords = "liothyronine;  mitogen activated protein kinase p38;  thyroid hormone;  liothyronine;  thyroid hormone receptor alpha, cell damage;  coronavirus disease 2019;  critically ill patient;  drug use;  human;  Letter;  mortality;  natural killer cell;  priority journal;  septic shock;  virus entry;  virus load;  virus replication;  Betacoronavirus;  Coronavirus infection;  critical illness;  pandemic;  virus pneumonia, Betacoronavirus;  Coronavirus Infections;  Critical Illness;  Humans;  Pandemics;  Pneumonia, Viral;  Thyroid Hormone Receptors alpha;  Triiodothyronine"
}